485Wire StoriesGrab Reports Second Quarter 2022 Results
Q2 record Revenue of $321 million, up 79% year-over-year Q2 GMV of $5.1 billion, up 30% year-over-year Q2 Loss for the period...
- 557Wire Stories
Genius Group Enters into a Securities Purchase Agreement for US$18.13 Million Private Placement
SINGAPORE–(BUSINESS WIRE)–$GNS #GNS–Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group, has entered...
- 582Wire Stories
LYNPARZA® (olaparib) Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the...
- 525Wire Stories
Hansen Powers Customer Care and Billing for Allente
MELBOURNE, Australia–(BUSINESS WIRE)–Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water and communications industries, is pleased...
- 807News
A.S. Watson’s Move to Invest USD400M in Supply Chain Transformation Has Strengthened its O+O Capabilities and Competitive Position During the Pandemic
HONG KONG SAR – Media OutReach – 25 August 2022 – A.S. Watson Group has gained widespread and overwhelming recognition in the...
- 480Wire Stories
PropertyGuru Reports Second Quarter 2022 Results
Revenues Grow 44% Year Over Year in Second Quarter and 43% in First Half Total revenue of S$33.0 million in the second...
- 601Wire Stories
BLOCWARS Operator Blocverse DAO Announces Acquisition of Swagga Studio to Create Phygital Fashion Metaverse
NEW YORK–(BUSINESS WIRE)–Blocverse DAO, the operator of play-to-earn (P2E) project BLOCWARS, announces the acquisition of IP creator Swagga Studio to establish the...
- 482Wire Stories
eCloudvalley Is One of The Best Companies to Work for in Asia 2022
SINGAPORE–(BUSINESS WIRE)–eCloudvalley Digital Technology was recently named one of the Best Companies to Work for in Asia by the leading human resources...
- 542Wire Stories
Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E in Combination with KEYTRUDA® (pembrolizumab) in Cervical Cancer at European Society for Medical Oncology (ESMO) Congress 2022
SEOUL, South Korea–(BUSINESS WIRE)–Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics...
- 533News
ViewQwest and HKBN forge Strategic Partnership to offer One-Stop DX services in APAC
HONG KONG SAR- Media OutReach – 25 August 2022 – Award-winning Singapore telecommunications, network and security solutions provider, ViewQwest, and Hong Kong’s...
